glp 1 cardiac benefit The Cardiovascular Physiology of Glucagon-like Peptide-1 Receptor Agonists: From Macro-Level Outcomes to Micro-Level Mechanisms GLP-1 Receptor Agonists in Heart

These programs can be effective for some but may not address underlying metabolic issues that make weight loss challenging

While these effects are beneficial in metabolic regulation, they also underline the most reported adverse effects, namely, nausea, vomiting, and diarrhea, all gastro-intestinal related, particularly during the initiation or rapid dose escalation of therapy

At the end of the original 72-week study, people on the highest dose of either medication were randomized into two arms: the treatment group taking a once-daily dose of orforglipron and a placebo control group

Appetite changes within days to weeks